Starting a business is challenging enough. Starting a life sciences business can be downright daunting.
Life science startups must face complex regulations and funding challenges, on top of the usual registration, licensing, human resources and strategic planning hurdles that all small businesses must jump.
The Kauffman Life Science Ventures Summit, held on June 22-23, 2012 at the University of California-San Francisco, is ready to help aspiring and early-stage life science ventures clear those obstacles.
This first-time conference will answer the critical questions that founders of life science companies must address to start and grow viable companies.
Industry experts and successful entrepreneurs will provide practical guidance on how to commercialize innovations in each of four sectors: medical device, therapeutics, diagnostics, and digital health.
Speakers include, among others:
- Steve Blank, serial entrepreneur and author
- Stephen Spielberg, deputy commissioner for medical products and tobacco at the Food & Drug Administration
- Paul Yock, founder, Stanford Biodesign
- Karl Handelsman, managing director, CMEA Capita
- Kim Popovits, CEO, Genomic Health
Call for Applications
Up to 200 life science entrepreneurs will be selected based on two factors:
- how much they will benefit from the experience based on where they are in their early-stage entrepreneurial journey
- the commercial viability of their plan
The application deadline is April 2, 2012. Selected applicants will be advised by April 13.
Visit www.kauffman.org/lifescienceapp to learn more information and to apply.
Content contributed by Maria Meyers, U.S.SourceLink, America’s largest resource network for entrepreneurs